Are we ready to describe response or progression to immunotherapy in lung cancer?

[Display omitted] Immune checkpoint inhibitors have changed history and management of different tumor types, including non-small cell lung cancer (NSCLC). Response patterns may be more heterogeneous than those seen with cytotoxic chemotherapy. Besides atypical response patterns, new types of outcome...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical reviews in oncology/hematology 2019-06, Vol.138, p.112-119
Hauptverfasser:	Guaitoli, Giorgia, Baldessari, Cinzia, Bertolini, Federica, Tomasello, Chiara, Cascinu, Stefano, Barbieri, Fausto
Format:	Artikel
Sprache:	eng
Schlagworte:	Hyper-progressive disease Immune checkpoint inhibitors Non-small cell lung cancer Pseudo-progression Radiological evaluation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!